These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35347553)

  • 21. Thalassemia Minor and Major: Current Management.
    Choudhry VP
    Indian J Pediatr; 2017 Aug; 84(8):607-611. PubMed ID: 28435994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron-chelating therapies in a transfusion-dependent thalassaemia population in Thailand: a cost-effectiveness study.
    Luangasanatip N; Chaiyakunapruk N; Upakdee N; Wong P
    Clin Drug Investig; 2011; 31(7):493-505. PubMed ID: 21627338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
    Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-utility analysis of oral deferasirox versus infusional deferoxamine in transfusion-dependent β-thalassemia patients.
    Keshtkaran A; Javanbakht M; Salavati S; Mashayekhi A; Karimi M; Nuri B
    Transfusion; 2013 Aug; 53(8):1722-9. PubMed ID: 23241074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia.
    Chuansumrit A; Sirachainan N; Kitpoka P; Kadegasem P; Songdej D; Sasanakul W; Wongwerawattanakoon P
    Hemoglobin; 2019; 43(4-5):264-272. PubMed ID: 31760834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha and beta thalassemia.
    Muncie HL; Campbell J
    Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood transfusion therapy for β-thalassemia major and hemoglobin E β-thalassemia: Adequacy, trends, and determinants in Sri Lanka.
    Mettananda S; Pathiraja H; Peiris R; Wickramarathne N; Bandara D; de Silva U; Mettananda C; Premawardhena A
    Pediatr Blood Cancer; 2019 May; 66(5):e27643. PubMed ID: 30697927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
    Sii-Felice K; Giorgi M; Leboulch P; Payen E
    Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifying the Composite Time Trade-Off Method to Improve Its Discriminatory Power.
    Jakubczyk M; Lipman SA; Roudijk B; Norman R; Pullenayegum E; Yang Y; Gu NY; Stolk E
    Value Health; 2023 Feb; 26(2):280-291. PubMed ID: 36244905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS).
    Matza LS; Phillips GA; Howell TA; Ciffone N; Ahmad Z
    J Med Econ; 2020 Sep; 23(9):978-984. PubMed ID: 32479143
    [No Abstract]   [Full Text] [Related]  

  • 31. Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study.
    Alshamsi S; Hamidi S; Narci HO
    BMC Health Serv Res; 2022 Mar; 22(1):304. PubMed ID: 35248046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.
    Cappellini MD; Porter J; Origa R; Forni GL; Voskaridou E; Galactéros F; Taher AT; Arlet JB; Ribeil JA; Garbowski M; Graziadei G; Brouzes C; Semeraro M; Laadem A; Miteva D; Zou J; Sung V; Zinger T; Attie KM; Hermine O
    Haematologica; 2019 Mar; 104(3):477-484. PubMed ID: 30337358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia.
    Cappellini MD; Bejaoui M; Agaoglu L; Porter J; Coates T; Jeng M; Lai ME; Mangiagli A; Strauss G; Girot R; Watman N; Ferster A; Loggetto S; Abish S; Cario H; Zoumbos N; Vichinsky E; Opitz H; Ressayre-Djaffer C; Abetz L; Rofail D; Baladi JF
    Clin Ther; 2007 May; 29(5):909-917. PubMed ID: 17697909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current recommendations for chelation for transfusion-dependent thalassemia.
    Kwiatkowski JL
    Ann N Y Acad Sci; 2016 Mar; 1368(1):107-14. PubMed ID: 27186943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience.
    Pinto VM; Poggi M; Russo R; Giusti A; Forni GL
    Blood Rev; 2019 Nov; 38():100594. PubMed ID: 31416718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations.
    Lloyd A; Hodgkins P; Sasane R; Akehurst R; Sonuga-Barke EJ; Fitzgerald P; Nixon A; Erder H; Brazier J
    Patient; 2011; 4(4):247-57. PubMed ID: 21995830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2021 update on clinical trials in β-thalassemia.
    Musallam KM; Bou-Fakhredin R; Cappellini MD; Taher AT
    Am J Hematol; 2021 Nov; 96(11):1518-1531. PubMed ID: 34347889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan.
    Ho WL; Chung KP; Yang SS; Lu MY; Jou ST; Chang HH; Yang YL; Lin DT; Lin KH
    J Formos Med Assoc; 2013 Apr; 112(4):221-9. PubMed ID: 23537869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
    Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
    Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.